Angiotensin converting enzyme inhibitors Flashcards
What are two mechanisms of blocking the RAAS?
ACE inhibitors
Angiotensin II antagonists
Where is renin released from
The juxtaglomerular cells in the kidney
What causes the JG cells to release renin (3 mechanisms)
1) Low extracellular volumes detected by baroreceptors in the afferent arteriole of the kidney
2) Low extracellular volumes detected by cardiac and arterial baroreceptors which result in sympathetic activation and increase in circulating catecholamines–> activation of beta-1 receptors in kidneys–> renin release
3) Macula densa cells in the early distal tubule that sense reduction in Cl- concentration
What does angiotensin II bind to
Angiotensin type I and type II receptors. Type I receptor activation results in aldosterone release from the adrenal glands and other classical effects (vasoconstriction, sympathetic activation). Type II receptor more sparse, upregulated in injury causes counter effects –> vasodilation and natiuresis.
What does aldosterone bind to and what is its main effect
Mineralcorticoid receptors located in many tissues. Main effect is via MR receptor in kidneys whereby on activatioin there is upregulation of Na+ channels increasing Na+ reabsorption and K+ loss.
What are the effects of aldosterone not related to Na+ reabsorption
-Vasoconstriction, endothelial dysfunction, decreased
compliance and hypertrophy of peripheral arteries.
-Hyperplasia and fibrosis from fibroblasts.
-Hypertrophy and norepinephrine release from cardiac myocytes.
Describe how ACEi work
Initially by blocking conversion of angiotensin I to II. This effect causes reduced Angitensin II and aldosterone levels in the first few weeks. Then Chymase takes over the conversion. Secondary effects is via the increase in bradykinins. ACE breaks down bradykinins so inhibition of this increases levels- bradykinins are vasodilators via release of NO and prostacyclin.
Name two ACEi
Cilazapril
Captopril
What are six effects of ACEi and AIIA
V asodilation
Decrease arterial and venous pressure
Decrease ventricular preload and afterload
Decrease blood volume through natiuresis and dieuresis
Decrease sympathetic activity
Decrease cardiac and vascular hypertrophy
ACEi indications
HTN (monotherapy or with a diuretic)
CHF (multiple therapy with diueretic, beta blocker, and aldosterone antagonist)
AIIA indications
When ACE inhibitor not tolerated (more evidence that ACEi improve outcomes)
Common treatment regime for CHF
Diuretic, beta blocker, ACEi, sprironolactone (aldosterone antagonist)
Side effects of ACEi
Dry cough (due to bradykinin increase) Hyperkalemia Renal function deterioration (due to decreased perfusion) Hypotension Angiodema (bradykinins)
Absolute contraindications for ACEi and AIIA
Pregnancy (AII invovled in fetal renal development)
Bilateral renal artery stenosis
What is the relationship between ACEi and diabetes
Reduction in diabetes risk as Angiotensin II causes pro-inflammation, increased sympathetic activity, impaired insulin signalling, impari pancreatic functioning and reduced insulin sensitivity.